717 results on '"CARDIAC arrest"'
Search Results
2. Diagnosis of cardiac sarcoidosis in patients presenting with cardiac arrest or life-threatening arrhythmias.
- Author
-
Hatipoglu, Suzan, Gardezi, Syed K. M., Azzu, Alessia, Baksi, John, Alpendurada, Francisco, Izgi, Cemil, Khattar, Raj, Kouranos, Vasileios, Wells, Athol Umfrey, Sharma, Rakesh, Wechalekar, Kshama, Pennell, Dudley J., and Mohiaddin, Raad
- Subjects
SARCOIDOSIS ,ARRHYTHMIA ,CARDIAC patients ,CARDIAC arrest ,HEART conduction system ,DIAGNOSIS ,CARDIAC magnetic resonance imaging - Published
- 2023
- Full Text
- View/download PDF
3. Interventional management of out-of-hospital cardiac arrest.
- Author
-
Karam, Nicole and Spaulding, Christian
- Subjects
CARDIAC arrest ,IMPLANTABLE cardioverter-defibrillators ,AUTOMATED external defibrillation ,CORONARY thrombosis ,RETURN of spontaneous circulation ,PATIENT selection - Published
- 2023
- Full Text
- View/download PDF
4. Pre-arrest comorbidity burden and the future risk of out-of-hospital cardiac arrest in Korean adults.
- Author
-
Seok-In Hong, Youn-Jung Kim, Ye-Jee Kim, and Won Young Kim
- Subjects
CARDIAC arrest ,KOREANS ,INTERNATIONAL Statistical Classification of Diseases & Related Health Problems - Published
- 2023
- Full Text
- View/download PDF
5. Selection of patients for mechanical circulatory support for refractory out-of-hospital cardiac arrest.
- Author
-
Linde, Louise, Mørk, Sivagowry Rasalingam, Gregers, Emilie, Andreasen, Jo Bønding, Lassen, Jens Flensted, Ravn, Hanne Berg, Schmidt, Henrik, Riber, Lars Peter, Thomassen, Sisse Anette, Laugesen, Helle, Eiskjær, Hans, Terkelsen, Christian Juhl, Christensen, Steffen, Tang, Mariann, Moeller-Soerensen, Hasse, Holmvang, Lene, Kjaergaard, Jesper, Hassager, Christian, and Moller, Jacob Eifer
- Subjects
PATIENT selection ,ARTIFICIAL blood circulation ,CARDIAC arrest ,INTENSIVE care units ,CARDIOPULMONARY resuscitation - Abstract
Objective: To describe characteristics of patients admitted with refractory cardiac arrest for possible extracorporeal cardiopulmonary resuscitation (ECPR) and gain insight into the reasons for refraining from treatment in some.Methods: Nationwide retrospective cohort study involving all tertiary centres providing ECPR in Denmark. Consecutive patients admitted with ongoing chest compression for evaluation for ECPR treatment were enrolled. Presenting characteristics, duration of no-flow and low-flow time, end-tidal carbon dioxide (ETCO2), lactate and pH, and recording of reasons for refraining from ECPR documented by the treating team were recorded. Outcomes were survival to intensive care unit admission and survival to hospital discharge.Results: Of 579 patients admitted with refractory cardiac arrest for possible ECPR, 221 patients (38%) proceeded to ECPR and 358 patients (62%) were not considered candidates. Median prehospital low-flow time was 70 min (IQR 56 to 85) in ECPR patients and 62 min (48 to 81) in no-ECPR patients, p<0.001. Intra-arrest transport was more than 50 km in 92 (42%) ECPR patients and 135 in no-ECPR patients (38%), p=0.25. The leading causes for not initiating ECPR stated by the treating team were duration of low-flow time in 39%, severe metabolic derangement in 35%, and in 31% low ETCO2. The prevailing combination of contributing factors were non-shockable rhythm, low ETCO2, and metabolic derangement or prehospital low-flow time combined with low ETCO2. Survival to discharge was only achieved in six patients (1.7%) in the no-ECPR group.Conclusions: In this large nationwide study of patients admitted for possible ECPR, two-thirds of patients were not treated with ECPR. The most frequent reasons to abstain from ECPR were long duration of prehospital low-flow time, metabolic derangement and low ETCO2. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
6. Heartbeat: improving outcomes after out-of-hospital cardiac arrest.
- Author
-
Otto, Catherine M.
- Subjects
IMPLANTABLE cardioverter-defibrillators ,MITRAL valve insufficiency ,VENTRICULAR arrhythmia ,CARDIAC arrest ,SEX factors in disease - Published
- 2023
- Full Text
- View/download PDF
7. Exercise prescription in individuals with hypertrophic cardiomyopathy: what clinicians need to know.
- Author
-
Gati, Sabiha and Sharma, Sanjay
- Subjects
EXERCISE therapy ,CARDIAC hypertrophy ,QUALITY of life ,CARDIAC arrest ,DISEASE complications - Abstract
Hypertrophic cardiomyopathy (HCM) is the most frequently cited cause of exercise-related sudden cardiac death (SCD) in young individuals and has claimed the lives of some high-profile athletes. The circumstantial link between exercise and SCD from HCM has resulted in conservative exercise recommendations which focus on activities that should be avoided rather than the minimal amount of physical activity required to reap the multiple rewards of exercise. Consequently, most patients with HCM are confined to a sedentary lifestyle through fear of SCD, with accruing risk factors such as obesity and low cardiorespiratory fitness that confer a worse prognosis. Recent exercise programmes in asymptomatic and symptomatic individuals with HCM have shown that mild and moderate exercise is safe and accompanied by increased functional capacity and improved quality of life. Population studies also reveal that individuals with HCM in the higher quartiles of self-reported physical activity have lower total cardiovascular mortality compared with those in the lower quartiles. The impact of vigorous exercise on the natural history of HCM is unknown, although current experience suggests that affected adults with mild morphology and absence of high-risk factors may partake in such activity without adverse events. This review highlights the evidence base that has resulted in a paradigm shift in the approach to exercise in HCM and liberalised recent international exercise guidelines in HCM. Practical tips for prescribing exercise in symptomatic patients and relevant precautions are provided to aid clinicians when recommending exercise as part of the management plan for all patients with HCM. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
8. Proteomics profiling reveals a distinct high-risk molecular subtype of hypertrophic cardiomyopathy.
- Author
-
Lusha W. Liang, Yoshihiko Raita, Kohei Hasegawa, Fifer, Michael A., Maurer, Mathew S., Reilly, Muredach P., Yuichi J. Shimada, Liang, Lusha W, Raita, Yoshihiko, Hasegawa, Kohei, and Shimada, Yuichi J
- Subjects
HEART failure ,HYPERTROPHIC cardiomyopathy ,VENTRICULAR outflow obstruction ,PROTEOMICS ,RETURN of spontaneous circulation ,EVALUATION research ,RESEARCH funding ,CARDIAC hypertrophy ,LONGITUDINAL method ,RESEARCH ,RESEARCH methodology ,CARDIAC arrest ,COMPARATIVE studies ,DISEASE complications - Abstract
Objective: Hypertrophic cardiomyopathy (HCM) is a heterogeneous disease, likely encompassing several subtypes of disease with distinct biological mechanisms (ie, molecular subtypes). Current models based solely on clinical data have yielded limited accuracy in predicting the risk of major adverse cardiovascular events (MACE). Our aim in this study was to derive molecular subtypes in our multicentre prospective cohort of patients with HCM using proteomics profiling and to examine their longitudinal associations with MACE.Methods: We applied unsupervised machine learning methods to plasma proteomics profiling data of 1681 proteins from 258 patients with HCM who were prospectively followed for a median of 2.8 years. The primary outcome was MACE, defined as a composite of arrhythmia, heart failure, stroke and sudden cardiac death.Results: We identified four molecular subtypes of HCM. Time-to-event analysis revealed significant differences in MACE-free survival among the four molecular subtypes (plogrank=0.007). Compared with the reference group with the lowest risk of MACE (molecular subtype A), patients in molecular subtype D had a higher risk of subsequently developing MACE, with an HR of 3.41 (95% CI 1.54 to 7.55, p=0.003). Pathway analysis of proteins differentially regulated in molecular subtype D demonstrated an upregulation of the Ras/mitogen-activated protein kinase and associated pathways, as well as pathways related to inflammation and fibrosis (eg, transforming growth factor-β pathway).Conclusions: Our prospective plasma proteomics study not only exhibited the presence of HCM molecular subtypes but also identified pathobiological mechanisms associated with a distinct high-risk subtype of HCM. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
9. Bayesian analysis of amiodarone or lidocaine versus placebo for out-of-hospital cardiac arrest.
- Author
-
Lane, Daniel J., Grunau, Brian, Kudenchuk, Peter, Dorian, Paul, Wang, Henry E., Daya, Mohamud R., Lupton, Joshua, Vaillancourt, Christian, Masashi Okubo, Davis, Daniel, Rea, Thomas, Yannopoulos, Demetris, Christenson, Jim, Scheuermeyer, Frank, and Okubo, Masashi
- Subjects
ADVANCED cardiac life support ,BAYESIAN analysis ,ARRHYTHMIA ,CARDIAC arrest ,AMIODARONE ,LIDOCAINE ,PLACEBOS ,VENTRICULAR fibrillation treatment ,MYOCARDIAL depressants ,CLINICAL trials ,PROBABILITY theory - Abstract
Objective: Clinical trials for patients with shock-refractory out-of-hospital cardiac arrest (OHCA), including the Amiodarone, Lidocaine or Placebo (ALPS) trial, have been unable to demonstrate definitive benefit after treatment with antiarrhythmic drugs. A Bayesian approach, combining the available evidence, may yield additional insights.Methods: We conducted a reanalysis of the ALPS trial comparing treatment with amiodarone or lidocaine with placebo in patients with OHCA following shock-refractory ventricular fibrillation or ventricular tachycardia (VF/VT). We used Bayesian regression to assess the probability of improved survival or improved neurological outcome on the 7-point modified Rankin Scale. We derived weak, moderate and strong priors from a previous clinical trial.Results: The original ALPS trial randomised 3026 adult patients with OHCA to amiodarone (n=974, survival to hospital discharge 24.4%), lidocaine, (n=993, survival 23.7%) or placebo (n=1059, survival 21.0%). In our reanalysis the probability of improved survival from amiodarone ranged from 83% (strong prior) to 95% (weak prior) compared with placebo and from 78% (strong) to 90% (weak) for lidocaine-an estimated improvement in survival of 2.9% (IQR 1.4%-3.8%) for amiodarone and 1.7% (IQR 0.84%-3.2%) for lidocaine over placebo (moderate prior). The probability of improved neurological outcome from amiodarone ranged from 96% (weak) to 99% (strong) compared with placebo and from 88% (weak) to 96% (strong) for lidocaine.Conclusions: In a Bayesian reanalysis of patients with shock-resistant VF/VT OHCA, treatment with amiodarone had high probabilities of improved survival and neurological outcome, while treatment with lidocaine had a more modest benefit. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
10. Heartbeat: sudden cardiac death risk in patients with hypertrophic cardiomyopathy.
- Author
-
Otto, Catherine M.
- Subjects
HEART failure ,CARDIAC arrest ,VENTRICULAR outflow obstruction ,VENTRICULAR ejection fraction ,HYPERTROPHIC cardiomyopathy ,MEDICAL examinations of athletes ,SPECKLE tracking echocardiography - Published
- 2023
- Full Text
- View/download PDF
11. Non-invasive markers for sudden cardiac death risk stratification in dilated cardiomyopathy.
- Author
-
Pooranachandran, Vivetha, Nicolson, Will, Vali, Zakariyya, Xin Li, Ng, G. Andre, and Li, Xin
- Subjects
LEFT heart ventricle ,IMPLANTABLE cardioverter-defibrillators ,RISK assessment ,PSYCHOLOGICAL tests ,DILATED cardiomyopathy ,CARDIAC arrest ,RESEARCH funding ,STROKE volume (Cardiac output) ,HEART physiology ,DISEASE complications - Abstract
Dilated cardiomyopathy (DCM) is a common yet challenging cardiac disease. Great strides have been made in improving DCM prognosis due to heart failure but sudden cardiac death (SCD) due to ventricular arrhythmias remains significant and challenging to predict. High-risk patients can be effectively managed with implantable cardioverter defibrillators (ICDs) but because identification of what is high risk is very limited, many patients unnecessarily experience the morbidity associated with an ICD implant and many others are not identified and have preventable mortality. Current guidelines recommend use of left ventricular ejection fraction and New York Heart Association class as the main markers of risk stratification to identify patients who would be at higher risk of SCD. However, when analysing the data from the trials that these recommendations are based on, the number of patients in whom an ICD delivers appropriate therapy is modest. In order to improve the effectiveness of therapy with an ICD, the patients who are most likely to benefit need to be identified. This review article presents the evidence behind current guideline-directed SCD risk markers and then explores new potential imaging, electrophysiological and genetic risk markers for SCD in DCM. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
12. Sex differences in sudden cardiac death in a nationwide study of 54 028 deaths.
- Author
-
Skjelbred, Tobias, Rajan, Deepthi, Svane, Jesper, Lynge, Thomas Hadberg, and Tfelt-Hansen, Jacob
- Subjects
HUMAN reproduction ,CAUSES of death ,AUTOPSY ,DISEASE incidence ,CARDIAC arrest - Abstract
Objective: Sudden cardiac death (SCD) is a leading cause of death and is more common among males than females. Epidemiological studies of sex differences in SCD cases of all ages are sparse. The aim of this study was to examine differences in incidence rates, clinical characteristics, comorbidities and autopsy findings between male and female SCD cases.Methods: All deaths in Denmark in 2010 (54 028) were reviewed. Autopsy reports, death certificates, discharge summaries and nationwide health registries were reviewed to identify cases of SCD. Based on the available information, all deaths were subcategorised into definite, probable and possible SCD.Results: A total of 6867 SCD cases were identified, of which 3859 (56%) were males and 3008 (44%) were females. Incidence rates increased with age and were higher for male population across all age groups in the adult population. Average age at time of SCD was 71 years among males compared with 79 among females (p<0.01). The greatest difference in SCD incidence between males and females was found among the 35-50 years group with an incidence rate ratio of 3.7 (95% CI: 2.8 to 4.8). Compared with female SCD victims, male SCD victims more often had cardiovascular diseases and diabetes mellitus (p<0.01).Conclusion: This is the first nationwide study of sex differences in SCD across all ages. Differences in incidence rates between males and females were greatest among young adults and the middle-aged. Incidence rates of SCD among older female population approached that of the male population, despite having significantly more cardiovascular disease and diabetes in male SCD cases. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
13. Impact of cascade screening for catecholaminergic polymorphic ventricular tachycardia type 1.
- Author
-
Keiko Shimamoto, Seiko Ohno, Koichi Kato, Koichiro Takayama, Keiko Sonoda, Megumi Fukuyama, Takeru Makiyama, Satomi Okamura, Koko Asakura, Noriaki Imanishi, Yoshiaki Kato, Heima Sakaguchi, Tsukasa Kamakura, Mitsuru Wada, Kenichiro Yamagata, Kohei Ishibashi, Yuko Inoue, Koji Miyamoto, Satoshi Nagase, and Kengo Kusano
- Subjects
RESEARCH ,GENETIC mutation ,RESEARCH methodology ,EVALUATION research ,VENTRICULAR tachycardia ,COMPARATIVE studies ,CARDIAC arrest ,CALCIUM - Abstract
Objective: Human cardiac ryanodine receptor 2 (RYR2) shows autosomal-dominant inheritance in catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1); however, de novo variants have been observed in sporadic cases. Here, we investigated CPVT1-related RYR2 variant inheritance and its clinical significance between familial and de novo cases.Methods: We enrolled 82 independent CPVT1 probands (median age: 10.0 (7.0-13.0) years; 45 male) carrying the RYR2 variants and whose biological origin could be confirmed by parental genetic analysis: assured familial inheritance (familial group: n=24) and de novo variants (de novo group: n=58). We examined the clinical characteristics of the probands and their family members carrying the RYR2 variants.Results: In the de novo group, the RYR2 variants were more likely located in the C-terminus domain and less likely in the N-terminus domain than those in the familial group. The cumulative incidence of the first cardiac events (syncope and cardiac arrest (CA) or CA only) of the probands at the age of 5 and 10 years was higher in the de novo group than in the familial group. Nearly half of the probands in both groups experienced CA events before diagnosis. Only 37.5% of their genotype-positive parents had symptoms; however, at least 66.7% of the genotype-positive siblings were symptomatic.Conclusions: CPVT1 probands harbouring de novo RYR2 variants showed an earlier onset of symptoms than those with assured familial inheritance. Cascade screening may enable early diagnosis, risk stratification and prophylactic therapeutic intervention to prevent sudden cardiac death of probands and potential genotype-positive family members. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
14. Brugada syndrome: update and future perspectives.
- Author
-
Marsman, E. Madelief J., Postema, Pieter G., and Remme, Carol Ann
- Subjects
BRUGADA syndrome diagnosis ,BEHAVIORAL assessment ,BRUGADA syndrome ,CARDIAC arrest ,ELECTROCARDIOGRAPHY ,ARRHYTHMIA ,DISEASE complications - Abstract
Brugada syndrome (BrS) is an inherited cardiac disorder, characterised by a typical ECG pattern and an increased risk of arrhythmias and sudden cardiac death (SCD). BrS is a challenging entity, in regard to diagnosis as well as arrhythmia risk prediction and management. Nowadays, asymptomatic patients represent the majority of newly diagnosed patients with BrS, and its incidence is expected to rise due to (genetic) family screening. Progress in our understanding of the genetic and molecular pathophysiology is limited by the absence of a true gold standard, with consensus on its clinical definition changing over time. Nevertheless, novel insights continue to arise from detailed and in-depth studies, including the complex genetic and molecular basis. This includes the increasingly recognised relevance of an underlying structural substrate. Risk stratification in patients with BrS remains challenging, particularly in those who are asymptomatic, but recent studies have demonstrated the potential usefulness of risk scores to identify patients at high risk of arrhythmia and SCD. Development and validation of a model that incorporates clinical and genetic factors, comorbidities, age and gender, and environmental aspects may facilitate improved prediction of disease expressivity and arrhythmia/SCD risk, and potentially guide patient management and therapy. This review provides an update of the diagnosis, pathophysiology and management of BrS, and discusses its future perspectives. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
15. Arrhythmogenic right ventricular cardiomyopathy: a focused update on diagnosis and risk stratification.
- Author
-
Bosman, Laurens P. and te Riele, Anneline S. J. M.
- Subjects
ARRHYTHMOGENIC right ventricular dysplasia ,IMPLANTABLE cardioverter-defibrillators ,ARRHYTHMIA ,VENTRICULAR arrhythmia ,CARDIAC arrest ,VENTRICULAR tachycardia - Abstract
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited cardiomyopathy characterised by fibrofatty replacement of predominantly the right ventricle and high risk of ventricular arrhythmias and sudden cardiac death (SCD). Early diagnosis and accurate risk assessment are challenging yet essential for SCD prevention. This manuscript summarises the current state of the art on ARVC diagnosis and risk stratification. Improving the 2010 diagnostic criteria is an ongoing discussion. Several studies suggest that early diagnosis may be facilitated by including deformation imaging ('strain') for objective assessment of wall motion abnormalities, which was shown to have high sensitivity for preclinical disease. Adding fibrofatty replacement detected by late gadolinium enhancement or T1 mapping in cardiac MRI as criterion for diagnosis is increasingly suggested but requires more supporting evidence from consecutive patient cohorts. In addition to the traditional right-dominant ARVC, standard criteria for arrhythmogenic cardiomyopathy (ACM) and arrhythmogenic left ventricular cardiomyopathy (ALVC) are on the horizon. After diagnosis confirmation, the primary management goal is SCD prevention, for which an implantable cardioverter-defibrillator is the only proven therapy. Prior studies determined that younger age, male sex, previous (non-) sustained ventricular tachycardia, syncope, extent of T-wave inversion, frequent premature ectopic beats and lower biventricular ejection fraction are risk factors for subsequent events. Previous implantable cardioverter-defibrillator indication guidelines were however limited to three expert-opinion flow charts stratifying patients in risk groups. Now, two multivariable risk prediction models (arvcrisk.com) combine the abovementioned risk factors to estimate individual risks. Of note, both the flow charts and prediction models require clinical validation studies to determine which should be recommended. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
16. Implantable cardiac defibrillator events in patients with arrhythmogenic right ventricular cardiomyopathy.
- Author
-
Woźniak, Olgierd, Borowiec, Karolina, Konka, Marek, Cicha-Mikołajczyk, Alicja, Przybylski, Andrzej, Szumowski, Łukasz, Hoffman, Piotr, Poślednik, Krzysztof, and Biernacka, Elżbieta Katarzyna
- Subjects
IMPLANTABLE cardioverter-defibrillators ,ARRHYTHMOGENIC right ventricular dysplasia ,VENTRICULAR arrhythmia ,PATIENTS' rights ,ARRHYTHMIA - Abstract
Objective: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is associated with a risk of sudden cardiac death. Optimal risk stratification is still under debate. The main purpose of this long-term, single-centre observation was to analyse predictors of appropriate and inappropriate implantable cardioverter-defibrillator (ICD) interventions in the population of patients with ARVC with a high risk of life-threatening arrhythmias.Methods: The study comprised 65 adult patients (median age 40 years, 48 men) with a definite diagnosis of ARVC who received ICD over a time span of 20 years in primary (40%) or secondary (60%) prevention of sudden cardiac death. The study endpoints were first appropriate and inappropriate ICD interventions (shock or antitachycardia pacing) after device implantation.Results: During a median follow-up of 7.75 years after ICD implantation, nine patients died and six individuals underwent heart transplantation. Appropriate ICD interventions occurred in 43 patients (66.2%) and inappropriate ICD interventions in 18 patients (27.7%). Multivariable analysis using cause-specific hazard model identified three predictors of appropriate ICD interventions: right ventricle dysfunction (cause-specific HR 2.85, 95% CI 1.56 to 5.21, p<0.001), age <40 years at ICD implantation (cause-specific HR 2.37, 95% CI 1.13 to 4.94, p=0.022) and a history of sustained ventricular tachycardia (cause-specific HR 2.55, 95% CI 1.16 to 5.63, p=0.020). Predictors of inappropriate ICD therapy were not found. Complications related to ICD implantation occurred in 12 patients.Conclusions: Right ventricle dysfunction, age <40 years and a history of sustained ventricular tachycardia were predictors of appropriate ICD interventions in patients with ARVC. The results may be used to improve risk stratification before ICD implantation. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
17. Risk of out-of-hospital cardiac arrest in patients with bipolar disorder or schizophrenia.
- Author
-
Barcella, Carlo Alberto, Kragholm, Kristian, Christensen, Daniel, Gerds, Thomas A., Polcwiartek, Christoffer, Wissenberg, Mads, Bang, Casper, Folke, Fredrik, Torp-Pedersen, Christian, Kessing, Lars Vedel, Gislason, Gunnar Hilmar, Søndergaard, Kathrine Bach, Mohr, Grimur, and Bach Søndergaard, Kathrine
- Subjects
BIPOLAR disorder ,CARDIAC arrest ,CARDIAC patients ,DISEASE risk factors ,SCHIZOPHRENIA ,CARDIOPULMONARY resuscitation ,RESEARCH ,RESEARCH methodology ,ACQUISITION of data ,RETROSPECTIVE studies ,CASE-control method ,MEDICAL cooperation ,EVALUATION research ,COMPARATIVE studies ,EMERGENCY medical services ,DISEASE complications - Abstract
Objective: Patients with bipolar disorder and schizophrenia are at high cardiovascular risk; yet, the risk of out-of-hospital cardiac arrest (OHCA) compared with the general population remains scarcely investigated.Methods: We conducted a nested case-control study using Cox regression to assess the association of bipolar disorder and schizophrenia with the HRs of OHCA of presumed cardiac cause (2001-2015). Reported are the HRs with 95% CIs overall and in subgroups defined by established cardiac disease, cardiovascular risk factors and psychotropic drugs.Results: We included 35 017 OHCA cases and 175 085 age-matched and sex-matched controls (median age 72 years and 66.9% male). Patients with bipolar disorder or schizophrenia had overall higher rates of OHCA compared with the general population: HR 2.74 (95% CI 2.41 to 3.13) and 4.49 (95% CI 4.00 to 5.10), respectively. The association persisted in patients with both cardiac disease and cardiovascular risk factors at baseline (bipolar disorder HR 2.14 (95% CI 1.72 to 2.66), schizophrenia 2.84 (95% CI 2.20 to 3.67)) and among patients without known risk factors (bipolar disorder HR 2.14 (95% CI 1.09 to 4.21), schizophrenia HR 5.16 (95% CI 3.17 to 8.39)). The results were confirmed in subanalyses only including OHCAs presenting with shockable rhythm or receiving an autopsy. Antipsychotics-but not antidepressants, lithium or antiepileptics (the last two only tested in bipolar disorder)-increased OHCA hazard compared with no use in both disorders.Conclusions: Patients with bipolar disorder or schizophrenia have a higher rate of OHCA compared with the general population. Cardiac disease, cardiovascular risk factors and antipsychotics represent important underlying mechanisms. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
18. N-terminal pro-brain natriuretic peptide and sudden cardiac death in hypertrophic cardiomyopathy.
- Author
-
Guixin Wu, Jie Liu, Shuiyun Wang, Shiqin Yu, Ce Zhang, Dong Wang, Mo Zhang, Yaoyao Yang, Lianming Kang, Shihua Zhao, Rutai Hui, Yubao Zou, Jizheng Wang, Lei Song, Wu, Guixin, Liu, Jie, Wang, Shuiyun, Yu, Shiqin, Zhang, Ce, and Wang, Dong
- Subjects
BRAIN natriuretic factor ,CARDIAC arrest ,HYPERTROPHIC cardiomyopathy ,RECEIVER operating characteristic curves ,HEART fibrosis - Abstract
Objective: Elevated levels of N-terminal pro-brain natriuretic peptide (NT-proBNP) are associated with heart failure-related death in hypertrophic cardiomyopathy (HCM), but the relationship between NT-proBNP level and sudden cardiac death (SCD) in HCM remains undefined.Methods: The study prospectively enrolled 977 unrelated patients with HCM with available NT-proBNP results who were prospectively enrolled and followed for 3.0±2.1 years. The Harrell's C-statistic under the receiver operating characteristic curve was calculated to evaluate discrimination performance. A combination model was constructed by adding NT-proBNP tertiles to the HCM Risk-SCD model. The correlation between log NT-proBNP level and cardiac fibrosis as measured by late gadolinium enhancement (LGE) or Masson's staining was analysed.Results: During follow-up, 29 patients had SCD. Increased log NT-proBNP levels were associated with an increased risk of SCD events (adjusted HR 22.27, 95% CI 10.93 to 65.63, p<0.001). The C-statistic of NT-proBNP in predicting SCD events was 0.80 (p<0.001). The combined model significantly improved the predictive efficiency of the HCM Risk-SCD model from 0.72 to 0.81 (p<0.05), with a relative integrated discrimination improvement of 0.002 (p<0.001) and net reclassification improvement of 0.67 (p<0.001). Furthermore, log NT-proBNP levels were significantly correlated with cardiac fibrosis as detected either by LGE (r=0.257, p<0.001) or by Masson's trichrome staining in the myocardium (r=0.198, p<0.05).Conclusion: NT-proBNP is an independent predictor of SCD in patients with HCM and may help with risk stratification of this disease. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
19. Heartbeat: sex-based discrepancies in survival from sudden cardiac death.
- Author
-
Otto, Catherine M.
- Subjects
CARDIAC arrest ,HEART beat - Published
- 2022
- Full Text
- View/download PDF
20. Long-term outcomes of adult out-of-hospital cardiac arrest in Queensland, Australia (2002-2014): incidence and temporal trends.
- Author
-
Pemberton, Katherine, Franklin, Richard C., Bosley, Emma, and Watt, Kerrianne
- Subjects
ADULTS ,CARDIAC arrest ,ADVANCED cardiac life support ,ARRHYTHMIA ,MEDICAL sciences ,QUALITY of life ,COMA ,GENDER ,HEART disease complications ,HEART disease diagnosis ,HEART disease epidemiology ,CARDIOPULMONARY resuscitation ,HEALTH services accessibility ,SOCIAL determinants of health ,AGE distribution ,DISEASE incidence ,SEX distribution ,EMERGENCY medical services ,SOCIAL classes ,QUALITY assurance - Abstract
Objective: To describe annual incidence and temporal trends (2002-2014) in incidence of long-term outcomes of adult out-of-hospital cardiac arrest (OHCA) of presumed cardiac aetiology attended by Queensland Ambulance Service (QAS) paramedics, by age, gender, geographical remoteness and socioeconomic status (SES).Methods: This is a retrospective cohort study. Cases were identified using the QAS OHCA Registry and were linked with entries in the Queensland Hospital Admitted Patient Data Collection and the Queensland Registrar General Death Registry. Population data were obtained from the Australian Bureau of Statistics to calculate incidence. Inclusion criteria were adult (18+ years) residents of Queensland who suffered OHCA of presumed cardiac aetiology and survived to hospital admission. Analyses were undertaken by three mutually exclusive outcomes: (1) survival to less than 30 days (Surv<30 days); (2) survival from 30 to 364 days (Surv30-364 days); and (3) survival to 365 days or more (Surv365+ days). Incidence rates were calculated for each year by gender, age, remoteness and SES. Temporal trends were analysed.Results: Over the 13 years there were 4393 cases for analyses. The incidence of total admitted events (9.72-10.13; p<0.01), Surv30-364 days (0.18-0.42; p<0.05) and Surv365+ days (1.94-4.02; p<0.001) increased significantly over time; no trends were observed for Surv<30 days. An increase in Surv365+ days over time was observed in all remoteness categories and most SES categories.Conclusion: Evidence suggests that implemented strategies to improve outcomes from OHCA have been successful and penetrated groups living in more remote locations and the lower socioeconomic groups. These populations still require focus. Ongoing reporting of long-term outcomes from OHCA should be undertaken using population-based incidence. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
21. Temporal trends and sex differences in sudden cardiac death in the Copenhagen City Heart Study.
- Author
-
Ågesen, Frederik Nybye, Lynge, Thomas Hadberg, Blanche, Paul, Banner, Jytte, Prescott, Eva, Jabbari, Reza, and Tfelt-Hansen, Jacob
- Subjects
CARDIAC arrest ,HEART ,CORONARY artery disease ,DEATH certificates ,COMORBIDITY ,CAUSES of death ,RESEARCH ,AUTOPSY ,RESEARCH methodology ,CARDIOVASCULAR diseases ,DISEASE incidence ,MEDICAL cooperation ,EVALUATION research ,COMPARATIVE studies ,QUESTIONNAIRES ,URBAN health ,DEMOGRAPHY ,LONGITUDINAL method - Abstract
Objective: More knowledge about the development of sudden cardiac death (SCD) in the general population is needed to develop meaningful predictors of SCD. Our aim with this study was to estimate the incidence of SCD in the general population and examine the temporal changes, demographics and clinical characteristics.Methods: All participants in the Copenhagen City Heart Study were followed from 1993 to 2016. All death certificates, autopsy reports and national registry data were used to identify all cases of SCD.Results: A total of 14 562 subjects were included in this study. There were 8394 deaths with all information available, whereof 1335 were categorised as SCD. The incidence of SCD decreased during the study period by 41% for persons aged 40-90 years, and the standardised incidence rates decreased from 504 per 100 000 person-years (95% CI 447 to 569) to 237 per 100 000 person-years (95% CI 195 to 289). The incidence rate ratio of SCD between men and women ≤75 years was 1.99 (95% CI 1.62 to 2.46). The proportion of SCD of all cardiac deaths decreased during the observation period and decreased with increasing age. Men had more cardiovascular comorbidities (OR 1.34, 95% CI 1.07 to 1.68, p<0. 01), and SCD was the first registered manifestation of cardiac disease in 50% of all cases.Conclusion: The incidence of SCD in the general population has declined significantly during the study period but should be further investigated for more recent variations as well as novel risk predictors for persons with low to medium risk of SCD. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
22. Machine learning model for predicting out-of-hospital cardiac arrests using meteorological and chronological data.
- Author
-
Takahiro Nakashima, Soshiro Ogata, Teruo Noguchi, Yoshio Tahara, Daisuke Onozuka, Satoshi Kato, Yoshiki Yamagata, Sunao Kojima, Taku Iwami, Tetsuya Sakamoto, Ken Nagao, Hiroshi Nonogi, Satoshi Yasuda, Koji Iihara, Neumar, Robert, Kunihiro Nishimura, Nakashima, Takahiro, Ogata, Soshiro, Noguchi, Teruo, and Tahara, Yoshio
- Subjects
CARDIAC arrest ,ADVANCED cardiac life support ,MACHINE learning ,METEOROLOGICAL services ,DATA mining ,FORECASTING ,BYSTANDER CPR - Abstract
Objectives: To evaluate a predictive model for robust estimation of daily out-of-hospital cardiac arrest (OHCA) incidence using a suite of machine learning (ML) approaches and high-resolution meteorological and chronological data.Methods: In this population-based study, we combined an OHCA nationwide registry and high-resolution meteorological and chronological datasets from Japan. We developed a model to predict daily OHCA incidence with a training dataset for 2005-2013 using the eXtreme Gradient Boosting algorithm. A dataset for 2014-2015 was used to test the predictive model. The main outcome was the accuracy of the predictive model for the number of daily OHCA events, based on mean absolute error (MAE) and mean absolute percentage error (MAPE). In general, a model with MAPE less than 10% is considered highly accurate.Results: Among the 1 299 784 OHCA cases, 661 052 OHCA cases of cardiac origin (525 374 cases in the training dataset on which fourfold cross-validation was performed and 135 678 cases in the testing dataset) were included in the analysis. Compared with the ML models using meteorological or chronological variables alone, the ML model with combined meteorological and chronological variables had the highest predictive accuracy in the training (MAE 1.314 and MAPE 7.007%) and testing datasets (MAE 1.547 and MAPE 7.788%). Sunday, Monday, holiday, winter, low ambient temperature and large interday or intraday temperature difference were more strongly associated with OHCA incidence than other the meteorological and chronological variables.Conclusions: A ML predictive model using comprehensive daily meteorological and chronological data allows for highly precise estimates of OHCA incidence. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
23. Prognostic value of plasma big endothelin-1 in left ventricular non-compaction cardiomyopathy.
- Author
-
Peng Fan, Ying Zhang, Yi-Ting Lu, Kun-Qi Yang, Pei-Pei Lu, Qiong-Yu Zhang, Fang Luo, Ya-Hui Lin, Xian-Liang Zhou, Tao Tian, Fan, Peng, Zhang, Ying, Lu, Yi-Ting, Yang, Kun-Qi, Lu, Pei-Pei, Zhang, Qiong-Yu, Luo, Fang, Lin, Ya-Hui, Zhou, Xian-Liang, and Tian, Tao
- Subjects
HEART failure ,ARRHYTHMIA ,PROGNOSIS ,PREPROENDOTHELIN ,CARDIOMYOPATHIES ,HEART transplantation ,RESEARCH ,ENDOTHELINS ,RESEARCH methodology ,CONGENITAL heart disease ,MAGNETIC resonance imaging ,IMPLANTABLE cardioverter-defibrillators ,MEDICAL cooperation ,EVALUATION research ,VENTRICULAR tachycardia ,HEART ventricles ,COMPARATIVE studies ,CARDIAC arrest ,VENTRICULAR fibrillation ,PEPTIDE hormones ,STROKE volume (Cardiac output) ,LONGITUDINAL method ,PEPTIDES ,DISEASE complications - Abstract
Objective: To determine the prognostic role of big endothelin-1 (ET-1) in left ventricular non-compaction cardiomyopathy (LVNC).Methods: We prospectively enrolled patients whose LVNC was diagnosed by cardiac MRI and who had big ET-1 data available. Primary end point was a composite of all-cause mortality, heart transplantation, sustained ventricular tachycardia/fibrillation and implanted cardioverter defibrillator discharge. Secondary end point was cardiac death or heart transplantation.Results: Altogether, 203 patients (median age 44 years; 70.9% male) were divided into high-level (≥0.42 pmol/L) and low-level (<0.42 pmol/L) big ET-1 groups according to the median value of plasma big ET-1 levels. Ln big ET-1 was positively associated with Ln N-terminal pro-brain natriuretic peptide, left ventricular diameter, but negatively related to age and Ln left ventricular ejection fraction. Median follow-up was 1.9 years (IQR 0.9-3.1 years). Kaplan-Meier analysis showed that, compared with patients with low levels of big ET-1, those with high levels were at greater risk for meeting both primary (p<0.001) and secondary (p<0.001) end points. The C-statistic estimation of Ln big ET-1 for predicting the primary outcome was 0.755 (95% CI 0.685 to 0.824, p<0.001). After adjusting for confounding factors, Ln big ET-1 was identified as an independent predictor of the composite primary outcome (HR 1.83, 95% CI 1.27 to 2.62, p=0.001) and secondary outcome (HR 1.93, 95% CI 1.32 to 2.83, p=0.001).Conclusions: Plasma big ET-1 may be a valuable index to predict the clinical adverse outcomes in patients with LVNC. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
24. Socioeconomic disparities in prehospital factors and survival after out-of-hospital cardiac arrest.
- Author
-
Møller, Sidsel, Wissenberg, Mads, Starkopf, Liis, Kragholm, Kristian, Hansen, Steen M., Ringgren, Kristian Bundgaard, Folke, Fredrik, Andersen, Julie, Hansen, Carolina Malta, Lippert, Freddy, Koeber, Lars, Gislason, Gunnar Hilmar, Torp-Pedersen, Christian, Gerds, Thomas A., and Malta Hansen, Carolina
- Subjects
ADVANCED cardiac life support ,BYSTANDER CPR ,CARDIAC arrest ,CARDIOPULMONARY resuscitation ,RESEARCH ,TIME ,RESEARCH methodology ,ACQUISITION of data ,MEDICAL cooperation ,EVALUATION research ,SOCIOECONOMIC factors ,COMPARATIVE studies ,PSYCHOLOGICAL tests ,EMERGENCY medical services - Abstract
Objective: It remains unknown whether patient socioeconomic factors affect interventions and survival after out-of-hospital cardiac arrest (OHCA), and whether a socioeconomic effect on bystander interventions affects survival. Therefore, this study examined patient socioeconomic disparities in prehospital factors and survival.Methods: From the Danish Cardiac Arrest Registry, patients with OHCA ≥30 years were identified, 2001-2014, and divided into quartiles of household income (highest, high, low, lowest). Associations between income and bystander cardiopulmonary resuscitation (CPR) and 30-day survival with bystander CPR as mediator were analysed by logistic regression and mediation analysis in private witnessed, public witnessed, private unwitnessed and public unwitnessed arrests, adjusted for confounders.Results: We included 21 480 patients. Highest income patients were younger, had higher education and were less comorbid relative to lowest income patients. They had higher odds for bystander CPR with the biggest difference in private unwitnessed arrests (OR 1.74, 95% CI 1.47 to 2.05). For 30-day survival, the biggest differences were in public witnessed arrests with 26.0% (95% CI 22.4% to 29.7%) higher survival in highest income compared with lowest income patients. Had bystander CPR been the same for lowest income as for highest income patients, then survival would be 25.3% (95% CI 21.5% to 29.0%) higher in highest income compared with lowest income patients, resulting in elimination of 0.79% (95% CI 0.08% to 1.50%) of the income disparity in survival. Similar trends but smaller were observed in low and high-income patients, the other three subgroups and with education instead of income. From 2002 to 2014, increases were observed in both CPR and survival in all income groups.Conclusion: Overall, lower socioeconomic status was associated with poorer prehospital factors and survival after OHCA that was not explained by patient or cardiac arrest-related factors. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
25. Heartbeat: can cardiogenetics reduce adverse events due to catecholaminergic polymorphic ventricular tachycardia?
- Author
-
Otto, Catherine M.
- Subjects
VENTRICULAR tachycardia ,CARDIAC arrest ,HEART beat ,CALCIUM - Published
- 2022
- Full Text
- View/download PDF
26. Predicting sudden cardiac death in adults with congenital heart disease.
- Author
-
Oliver, Jose M., Gallego, Pastora, Gonzalez, Ana Elvira, Avila, Pablo, Alonso, Andres, Garcia-Hamilton, Diego, Peinado, Rafael, Dos-Subirà, Laura, Pijuan-Domenech, Antonia, Rueda, Joaquín, odriguez-Puras, Maria-Jose, Garcia-Orta, Rocio, Martínez-Quintana, Efrén, Datino, Tomas, Fernandez-Aviles, Francisco, Bermejo, Javier, Rodriguez-Puras, Maria-Jose, and Spanish ACHD Network
- Subjects
CONGENITAL heart disease ,PULMONARY atresia ,CARDIAC arrest ,TRANSPOSITION of great vessels ,FORECASTING ,MYOCARDIAL infarction ,RESEARCH ,RESEARCH methodology ,PROGNOSIS ,CASE-control method ,DISEASE incidence ,MEDICAL cooperation ,EVALUATION research ,RISK assessment ,COMPARATIVE studies ,LOGISTIC regression analysis ,LONGITUDINAL method ,DISEASE complications - Abstract
Objectives: To develop, calibrate, test and validate a logistic regression model for accurate risk prediction of sudden cardiac death (SCD) and non-fatal sudden cardiac arrest (SCA) in adults with congenital heart disease (ACHD), based on baseline lesion-specific risk stratification and individual's characteristics, to guide primary prevention strategies.Methods: We combined data from a single-centre cohort of 3311 consecutive ACHD patients (50% male) at 25-year follow-up with 71 events (53 SCD and 18 non-fatal SCA) and a multicentre case-control group with 207 cases (110 SCD and 97 non-fatal SCA) and 2287 consecutive controls (50% males). Cumulative incidences of events up to 20 years for specific lesions were determined in the prospective cohort. Risk model and its 5-year risk predictions were derived by logistic regression modelling, using separate development (18 centres: 144 cases and 1501 controls) and validation (two centres: 63 cases and 786 controls) datasets.Results: According to the combined SCD/SCA cumulative 20 years incidence, a lesion-specific stratification into four clusters-very-low (<1%), low (1%-4%), moderate (4%-12%) and high (>12%)-was built. Multivariable predictors were lesion-specific cluster, young age, male sex, unexplained syncope, ischaemic heart disease, non-life threatening ventricular arrhythmias, QRS duration and ventricular systolic dysfunction or hypertrophy. The model very accurately discriminated (C-index 0.91; 95% CI 0.88 to 0.94) and calibrated (p=0.3 for observed vs expected proportions) in the validation dataset. Compared with current guidelines approach, sensitivity increases 29% with less than 1% change in specificity.Conclusions: Predicting the risk of SCD/SCA in ACHD can be significantly improved using a baseline lesion-specific stratification and simple clinical variables. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
27. Shortening time to defibrillation in shockable cardiac arrest matters: how do we do it?
- Author
-
Chatterjee, Neal A. and Rea, Thomas D.
- Subjects
CARDIAC arrest ,AUTOMATED external defibrillation ,BYSTANDER CPR - Published
- 2023
- Full Text
- View/download PDF
28. Sudden cardiac death in asymptomatic patients with aortic stenosis.
- Author
-
Minners, Jan, Rossebo, Anne, Chambers, John B., Gohlke-Baerwolf, Christa, Neumann, Franz-Josef, Wachtell, Kristian, and Jander, Nikolaus
- Subjects
CARDIAC arrest ,AORTIC stenosis ,BRUGADA syndrome ,CORONARY disease ,LEFT ventricular hypertrophy ,AORTIC valve diseases ,AORTIC valve transplantation ,HEART valve prosthesis implantation ,BODY surface area - Abstract
Objective: We retrospectively analysed outcome data from the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) study to assess the incidence and potential risk factors of sudden cardiac death (SCD) in this prospectively followed cohort of asymptomatic patients with aortic stenosis (AS).Methods: Of the 1873 patients included in SEAS, 1849 (99%) with mild to moderate AS (jet velocity 2.5-4.0 m/s at baseline) and available clinical, echocardiographic and follow-up data were analysed. Patients undergoing aortic valve replacement were censored at the time of operation.Results: During an overall follow-up of 46.1±14.6 months, SCD occurred in 27 asymptomatic patients (1.5%) after a mean of 28.3±16.6 months. The annualised event rate was 0.39%/year. The last follow-up echocardiography prior to the event showed mild to moderate stenosis in 22 and severe stenosis (jet velocity >4 m/s) in 5 victims of SCD. The annualised event rate after the diagnosis of severe stenosis was 0.60%/year compared with 0.46%/year in patients who did not progress to severe stenosis (p=0.79). Patients with SCD were older (p=0.01), had a higher left ventricular mass index (LVMI, p=0.001) and had a lower body mass index (BMI, p=0.02) compared with patients surviving follow-up. Cox regression analysis identified age (HR 1.06, 95% CI 1.01 to 1.11 per year, p=0.02), increased LVMI (HR 1.20, 95% CI 1.10 to 1.32 per 10 g/m2, p<0.001) and lower BMI (HR 0.87, 95% CI 0.79 to 0.97 per kg/m2, p=0.01) as independent risk factors of SCD.Conclusion: SCD in patients with asymptomatic mild to moderate AS is rare and strongly related to left ventricular hypertrophy but not stenosis severity. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
29. Effect of meteorological factors and air pollutants on out-of-hospital cardiac arrests: a time series analysis.
- Author
-
Jin-Ho Kim, Jinwook Hong, Jaehun Jung, Jeong-Soo Im, Kim, Jin-Ho, Hong, Jinwook, Jung, Jaehun, and Im, Jeong-Soo
- Subjects
TIME series analysis ,AIR pollutants ,CARDIAC arrest ,GRANGER causality test ,EMERGENCY medical services ,AIR pollution ,PARTICULATE matter ,DATABASES ,RESEARCH ,TEMPERATURE ,HUMIDITY ,TIME ,RESEARCH methodology ,WEATHER ,MEDICAL cooperation ,EVALUATION research ,SEASONS ,RISK assessment ,COMPARATIVE studies ,ENVIRONMENTAL exposure - Abstract
Objectives: We aimed to investigate the effects of meteorological factors and air pollutants on out-of-hospital cardiac arrest (OHCA) according to seasonal variations because the roles of these factors remain controversial to date.Methods: A total of 38 928 OHCAs of cardiac origin that occurred within eight metropolitan areas between 2012 and 2016 were identified from the Korean nationwide emergency medical service database. A time series multilevel approach based on Poisson analysis following a Granger causality test was used to analyse the influence of air pollution and 13 meteorological variables on OHCA occurrence.Results: Particulate matter (PM) ≤2.5 µm (PM2.5), average temperature, daily temperature range and humidity were significantly associated with a higher daily OHCA risk (PM2.5: 1.59%; 95% CI: 1.51% to 1.66% per 10µg/m3, average temperature 0.73%, 95% CI: 0.63% to 0.84% per 1°C, daily temperature range: 1.05%, 95% CI: 0.63% to 1.48% per 1°C, humidity -0.48, 95% CI: -0.40 to -0.56 per 1%) on lag day 1. In terms of the impact of these four risk factors in different seasons, average temperature and daily temperature range were highly associated with OHCA in the summer and winter, respectively. However, only PM2.5 elevation (to varying extents) was an independent and consistent OHCA risk factor irrespective of the season.Conclusions: PM2.5, average temperature, daily temperature range and humidity were independently associated with OHCA occurrence in a season-dependent manner. Importantly, PM2.5 was the only independent risk factor for OHCA occurrence irrespective of seasonal changes. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
30. Comorbidity and bystander cardiopulmonary resuscitation in out-of-hospital cardiac arrest.
- Author
-
Hirlekar, Geir, Jonsson, Martin, Karlsson, Thomas, Bäck, Maria, Rawshani, Araz, Hollenberg, Jacob, Albertsson, Per, and Herlitz, Johan
- Subjects
BYSTANDER CPR ,CARDIAC resuscitation ,CARDIAC arrest ,CARDIOPULMONARY resuscitation ,COMORBIDITY ,RESEARCH ,CONVALESCENCE ,TIME ,RESEARCH methodology ,RETROSPECTIVE studies ,ACQUISITION of data ,MEDICAL cooperation ,EVALUATION research ,RISK assessment ,TREATMENT effectiveness ,COMPARATIVE studies ,QUESTIONNAIRES - Abstract
OBJECTIVE: Cardiopulmonary resuscitation (CPR) performed before the arrival of emergency medical services (EMS) is associated with increased survival after out-of-hospital cardiac arrest (OHCA). The aim of this study was to determine whether patients who receive bystander CPR have a different comorbidity compared with patients who do not, and to determine the association between bystander CPR and 30-day survival when adjusting for such a possible difference. METHODS: Patients with witnessed OHCA in the Swedish Registry for Cardiopulmonary Resuscitation between 2011 and 2015 were included, and merged with the National Patient Registry. The Charlson Comorbidity Index (CCI) was used to measure comorbidity. Multiple logistic regression was used to examine the effect of CCI on the association between bystander CPR and outcome. RESULTS: In total, 11 955 patients with OHCA were included, 71% of whom received bystander CPR. Patients who received bystander CPR had somewhat lower comorbidity (CCI) than those who did not (mean±SD: 2.2±2.3 vs 2.5±2.4; p<0.0001). However, this difference in comorbidity had no influence on the association between bystander CPR and 30-day survival in a multivariable model including other possible confounders (OR 2.34 (95% CI 2.01 to 2.74) without adjustment for CCI and OR 2.32 (95% CI 1.98 to 2.71) with adjustment for CCI). CONCLUSION: Patients who undergo CPR before the arrival of EMS have a somewhat lower degree of comorbidity than those who do not. Taking this difference into account, bystander CPR is still associated with a marked increase in 30-day survival after OHCA. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
31. Implantable cardiac electronic device therapy for patients with a systemic right ventricle.
- Author
-
Barracano, Rosaria, Brida, Margarita, Guarguagli, Silvia, Palmieri, Rosalinda, Diller, Gerhard Paul, Gatzoulis, Michael A., and Wong, Tom
- Subjects
IMPLANTABLE cardioverter-defibrillators ,PATIENTS' rights ,ELECTRONIC equipment ,CONGENITAL heart disease ,TRANSPOSITION of great vessels ,CARDIAC arrest ,ARRHYTHMIA treatment ,CARDIAC surgery ,RIGHT heart ventricle ,CARDIAC pacing ,RISK assessment ,TREATMENT effectiveness ,HEART beat ,ACTION potentials ,ELECTRIC countershock ,HEART physiology ,ARRHYTHMIA ,CARDIAC pacemakers ,HEART conduction system - Abstract
The systemic right ventricle (SRV), defined as the morphological right ventricle supporting the systemic circulation, is relatively common in congenital heart disease (CHD). Our review aimed at examining the current evidence, knowledge gaps and technical considerations regarding implantable cardiac electronic device therapy in patients with SRV. The risk of sinus node dysfunction (SND) after atrial switch repair and/or complete heart block in congenitally corrected transposition of great arteries requiring permanent pacing increases with age. Similar to acquired heart disease, indication for pacing includes symptomatic bradycardia, SND and high degree atrioventricular nodal block. Right ventricular dysfunction and heart failure also represent important complications in SRV patients. Cardiac resynchronisation therapy (CRT) has been proposed to improve systolic function in SRV patients, although indications for CRT are not well defined and its potential benefit remains uncertain. Amongst adult CHD, patients with SRV are at the highest risk for sudden cardiac death (SCD). Nevertheless, risk stratification for SCD is scarce in this cohort and implantable cardioverter-defibrillator indication is currently limited to secondary prevention. Vascular access and the incidence of device-related complications, such as infections, inappropriate shocks and device system failure, represent additional challenges to implantable cardiac electronic device therapy in patients with SRV. A multidisciplinary approach with tertiary expertise and future collaborative research are all paramount to further the care for this challenging nonetheless ever increasing cohort of patients. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
32. Electrocardiographic associations with myocardial fibrosis among sudden cardiac death victims.
- Author
-
Holmström, Lauri, Haukilahti, Anette, Vähätalo, Juha, Kenttä, Tuomas, Appel, Henrik, Kiviniemi, Antti, Pakanen, Lasse, Huikuri, Heikki V., Myerburg, Robert J., and Junttila, Juhani
- Subjects
CARDIAC arrest ,FIBROSIS ,RESEARCH ,MYOCARDIUM ,PREDICTIVE tests ,CARDIOMYOPATHIES ,TIME ,RESEARCH methodology ,PROGNOSIS ,MEDICAL cooperation ,EVALUATION research ,RISK assessment ,COMPARATIVE studies ,ELECTROCARDIOGRAPHY ,HEART beat ,ACTION potentials ,QUESTIONNAIRES ,HEART conduction system - Abstract
Objective: A major challenge in reducing the incidence of sudden cardiac death (SCD) is the identification of patients at risk. Myocardial fibrosis has a substantial association with SCD risk but is difficult to identify among general populations. Our aim was to find electrocardiographic (ECG) markers of myocardial fibrosis among SCD victims.Methods: Study population was acquired from the Fingesture study, which has gathered data from 5869 consecutive autopsied SCD victims in Northern Finland between 1998 and 2017. The degree of fibrosis was determined in histological samples taken from the heart during autopsy and was categorised into four groups: (1) no fibrosis, (2) scattered mild fibrosis, (3) moderate patchy fibrosis and (4) substantial fibrosis. We were able to collect ECGs from 1100 SCD victims.Results: The mean age of the study subjects was 66±13 years and 75% were male. QRS duration in ECG correlated with the degree of fibrosis (p<0.001, β=0.153). Prevalence of fragmented QRS complex, pathological Q waves and T wave inversions correlated with increased degree of fibrosis (p<0.001 in each). Depolarisation abnormalities were observed both in ischaemic and non-ischaemic heart disease. Repolarisation abnormalities reached statistical significance only among ischaemic SCD victims. An abnormal ECG was observed in 75.3% of the subjects in group 1, 73.7% in group 2, 88.5% in group 3 and 91.7% in group 4 patients (p<0.001).Conclusions: Myocardial fibrosis was associated with QRS prolongation, deep Q waves, T wave inversions and QRS fragmentation. The results provide potentially useful non-invasive early recognition of patients with fibrotic cardiomyopathy and risk of SCD. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
33. Advanced imaging for risk stratification of sudden death in hypertrophic cardiomyopathy.
- Author
-
Ramchand, Jay, Fava, Agostina M., Chetrit, Michael, and Desai, Milind Y.
- Subjects
HYPERTROPHIC cardiomyopathy ,SUDDEN death ,LEFT ventricular hypertrophy ,CARDIAC arrest ,VENTRICULAR arrhythmia ,CARDIAC hypertrophy ,RISK assessment ,WORLD health ,DISEASE complications - Abstract
Hypertrophic cardiomyopathy (HCM) is a common inherited cardiac condition, which typically manifests as left ventricular hypertrophy. A small subset of patients with HCM have an increased risk of sudden cardiac death (SCD) from ventricular arrhythmias. Risk of SCD can be effectively reduced following implantation of implantable cardiac defibrillators (ICD), although this treatment carries a risk of complications such as inappropriate shocks. With this in mind, we turn to advances in cardiac imaging to guide risk stratification for SCD and to select the appropriate individual who may benefit from ICD implantation. In this review, we have taken the opportunity to briefly summarise the role of imaging in the diagnosis of HCM before focusing on how specific imaging features influence risk of SCD in patients with HCM. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
34. Characteristics of subjects with alcoholic cardiomyopathy and sudden cardiac death.
- Author
-
Hietanen, Siiri, Herajärvi, Johanna, Junttila, Juhani, Pakanen, Lasse, Huikuri, Heikki V., and Liisanantti, Janne
- Subjects
CARDIAC arrest ,CARDIOMYOPATHIES ,POOR communities ,HEART diseases ,CIRRHOSIS of the liver ,BRUGADA syndrome ,CAUSES of death ,RESEARCH ,SOCIAL participation ,RESEARCH methodology ,DISEASE incidence ,PROGNOSIS ,RETROSPECTIVE studies ,EVALUATION research ,MEDICAL cooperation ,COMPARATIVE studies ,PSYCHOLOGICAL tests ,ELECTROCARDIOGRAPHY ,ALCOHOLIC cardiomyopathy ,LONGITUDINAL method ,DISEASE complications - Abstract
Objective: To study social and clinical characteristics of victims of sudden cardiac death (SCD) due to alcoholic cardiomyopathy (ACM).Methods: The study population comprised a subset of Fingesture cohort. All subjects were verified SCD victims determined to have ACM as cause of death in medico-legal autopsy between 1998 and 2017 in Northern Finland. The Finnish Population Register Centre provided SCD victims' last place of residence. Population data of residential area were obtained from Statistics Finland.Results: From a total of 5869 SCD victims in Fingesture cohort, in 290 victims the cause of SCD was ACM (4.9%; median age 56 (50-62) years; 83% males). In 64 (22.1%) victims, the diagnosis of cardiac disease was made prior to death and in 226 (77.9%) at autopsy. There were no significant differences in autopsy findings between victims with or without known cardiac diagnosis, but steatohepatitis (94.5%) and liver cirrhosis (64,5%) were common in both groups. Alcoholism was more often recorded in the known cardiac disease group (64.1% vs 47.3%, p=0.023). Majority were included in the working age population (ie, under 65 years) (54.8% and 53.1%, p=0.810). In high-income communities, 28.8% of ACM SCD victims had previously diagnosed cardiac disease, the proportion in the middle-income and low-income communities was 18.6% (p=0.05).Conclusions: Majority of SCD victims due to ACM did not have previously diagnosed cardiac disease, but documented risk consumption of alcohol was common. This emphasises the importance of routine screening of alcohol consumption and signs of cardiomyopathy in heavy alcohol users in primary healthcare. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
35. Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy beyond ejection fraction.
- Author
-
Cannatà, Antonio, De Angelis, Giulia, Boscutti, Andrea, Normand, Camilla, Artico, Jessica, Gentile, Piero, Zecchin, Massimo, Heymans, Stephane, Merlo, Marco, and Sinagra, Gianfranco
- Subjects
DILATED cardiomyopathy ,CARDIAC arrest ,VENTRICULAR ejection fraction ,VENTRICULAR remodeling ,COMPETING risks ,LEFT heart ventricle ,WORLD health ,DISEASE incidence ,RISK assessment ,STROKE volume (Cardiac output) ,HEART physiology ,DISEASE complications - Abstract
Sudden cardiac death and arrhythmia-related events in patients with non-ischaemic dilated cardiomyopathy (NICM) have been significantly reduced over the last couple of decades as a result of evidence-based pharmacological and non-pharmacological therapeutic strategies. Nevertheless, the arrhythmic stratification in patients with NICM remains extremely challenging, and the simple indication based on left ventricular ejection fraction appears to be insufficient. Therefore, clinicians need to go beyond the current criteria for implantable cardioverter-defibrillator implantation in the direction of a multiparametric evaluation of arrhythmic risk. Several parameters for arrhythmic risk stratification, ranging from electrocardiographic, echocardiographic, imaging-derived and genetic markers, are crucial for proper arrhythmic risk stratification and a multiparametric evaluation of risk in patients with NICM. In particular, integration of cardiac magnetic resonance parameters (mostly late gadolinium enhancement) and specific genetic information (ie, presence of LMNA, PLN, FLNC mutations) appears fundamental for proper implementation of the current arrhythmic risk stratification. Finally, a novel approach focused on both arrhythmic risk and prediction of left ventricular reverse remodelling during follow-up might be useful for effective multiparametric and dynamic arrhythmic risk stratification in NICM. In the future, a complete and integrated evaluation might be mandatory to implement arrhythmic risk prediction in patients with NICM and to discriminate the competing risk between heart failure-related events and life-threatening arrhythmias. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
36. Cardiorespiratory fitness and heart rate recovery predict sudden cardiac death independent of ejection fraction.
- Author
-
Hernesniemi, Jussi A., Sipilä, Kalle, Tikkakoski, Antti, Tynkkynen, Juho T., Mishra, Pashupati P., Lyytikäinen, Leo-Pekka, Nikus, Kjell, Nieminen, Tuomo, Lehtimaki, Terho, and Kähönen, Mika
- Subjects
CARDIAC arrest ,HEART beat ,CARDIOPULMONARY fitness ,VENTRICULAR ejection fraction ,EXERCISE intensity ,RESEARCH ,RESEARCH methodology ,PROGNOSIS ,EVALUATION research ,MEDICAL cooperation ,RISK assessment ,COMPARATIVE studies ,STROKE volume (Cardiac output) ,LONGITUDINAL method - Abstract
Objective: To evaluate whether cardiorespiratory fitness (CRF) and heart rate recovery (HRR) associate with the risk of sudden cardiac death (SCD) independently of left ventricular ejection fraction (LVEF).Methods: The Finnish Cardiovascular Study is a prospective clinical study of patients referred to clinical exercise testing in 2001-2008 and follow-up until December 2013. Patients without pacemakers undergoing first maximal or submaximal exercise testing with cycle ergometer were included (n=3776). CRF in metabolic equivalents (METs) was estimated by achieving maximal work level. HRR was defined as the reduction in heart rate 1 min after maximal exertion. Adjudication of SCD was based on death certificates. LVEF was measured for clinical indications in 71.4% of the patients (n=2697).Results: Population mean age was 55.7 years (SD 13.1; 61% men). 98 SCDs were recorded during a median follow-up of 9.1 years (6.9-10.7). Mean CRF and HRR were 7.7 (SD 2.9) METs and 25 (SD 12) beats/min/min. Both CRF and HRR were associated with the risk of SCD in the entire study population (HRCRF0.47 (0.37-0.59), p<0.001 and HRHRR0.57 (0.48-0.67), p<0.001 with HR estimates corresponding to one SD increase in the exposure variables) and with CRF, HRR and LVEF in the same model (HRCRF0.60 (0.45-0.79), p<0.001, HRHRR0.65 (0.51-0.82), p<0.001) or adjusting additionally for all significant risk factors for SCD (LVEF, sex, creatinine level, history of myocardial infarction and atrial fibrillation, corrected QT interval) (HRCRF0.69 (0.52-0.93), p<0.01, HRHRR0.74 (0.58-0.95) p=0.02).Conclusions: CRF and HRR are significantly associated with the risk of SCD regardless of LVEF. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
37. Predicting sudden cardiac death in a general population using an electrocardiographic risk score.
- Author
-
Holkeri, Arttu, Eranti, Antti, Haukilahti, M. Anette E., Kerola, Tuomas, Kenttä, Tuomas V., Tikkanen, Jani T., Anttonen, Olli, Noponen, Kai, Seppänen, Tapio, Rissanen, Harri, Heliövaara, Markku, Knekt, Paul, Junttila, M. Juhani, Huikuri, Heikki V., and Aro, Aapo L.
- Subjects
BRUGADA syndrome ,CARDIAC arrest - Published
- 2020
- Full Text
- View/download PDF
38. Sudden cardiac death in families with premature cardiovascular disease.
- Author
-
Bruikman, Caroline, de Ronde, Maurice W. J., Amin, Ahmed, Levy, Sonja, Lof, Pien, de Ruijter, Ursula, Hovingh, Kees, Tan, Hanno L., and Pinto-Sietsma, Sara-Joan
- Subjects
CARDIAC arrest ,BRUGADA syndrome ,CARDIOVASCULAR diseases ,EARLY death ,ACADEMIC medical centers ,FAMILIAL hypercholesterolemia - Abstract
Objective: Sudden cardiac death (SCD) in families with premature atherosclerosis (PAS) is generally attributed to lethal arrhythmias during myocardial infarction. Yet, such arrhythmias may also arise from non-ischaemic inherited susceptibility. We aimed to test the hypothesis that Brugada syndrome is prevalent among families with PAS in which SCD occurred.Methods: We investigated all patients who underwent Ajmaline testing to screen them for Brugada syndrome because of unexplained familial SCD in the Amsterdam University Medical Centers between 2004 and 2017. We divided the cohort into two groups based on a positive family history for PAS. All individuals with a positive Ajmaline test were screened for SCN5A-mutation.Results: In families with SCD and PAS, the prevalence of positive Ajmaline test was similar to families with SCD alone (22% vs 19%). The number of SCD cases in families with SCD and PAS was higher (2.34 vs 1.63, p<0.001) and SCD occurred at older age in families with SCD and PAS (42 years vs 36 years, p<0.001), while the prevalence of SCN5A mutations was lower (3% vs 18%, p<0.05).Conclusions: Brugada syndrome has a similar prevalence in families with SCD and PAS as in families with SCD alone, although SCD in families with SCD and PAS occurs in more family members and at older age, while SCN5A mutations in these families are rare. This suggests that the SCD occurring in families with PAS could be related to an underlying genetic predisposition of arrhythmias, with a different genetic origin. It could be considered to screen families with SCD and PAS for Brugada syndrome. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
39. Moderated Poster Abstracts 1.
- Subjects
CORONARY care units ,MITRAL valve insufficiency ,MITRAL valve prolapse ,REVASCULARIZATION (Surgery) ,MEDICAL research ,POSTERS ,CARDIAC arrest ,ACUTE coronary syndrome - Published
- 2019
40. Low-normal systolic function and hypertrophic cardiomyopathy.
- Author
-
Rubis, Pawel
- Subjects
HEART failure ,HYPERTROPHIC cardiomyopathy ,GLOBAL longitudinal strain ,VENTRICULAR outflow obstruction ,HEART valve diseases ,CARDIAC arrest - Published
- 2023
- Full Text
- View/download PDF
41. Anticoagulation therapy in heart failure and sinus rhythm: a systematic review and meta-analysis.
- Author
-
Beggs, Simon A. S., Rørth, Rasmus, Gardner, Roy S., and McMurray, John J. V.
- Subjects
HEART failure ,META-analysis ,CARDIAC arrest ,CONGESTIVE heart failure ,MEDICAL sciences ,CORONARY disease - Abstract
Objective: Heart failure is a prothrombotic state, and it has been hypothesised that thrombosis and embolism cause non-fatal and fatal events in heart failure and reduced ejection fraction (HFrEF). We sought to determine the effect of anticoagulant therapy on clinical outcomes in patients with HFrEF who are in sinus rhythm.Methods: We conducted an updated systematic review and meta-analysis to examine the effect of anticoagulation therapy in patients with HFrEF in sinus rhythm. Our analysis compared patients randomised to anticoagulant therapy with those randomised to antiplatelet therapy, placebo or control, and examined the endpoints of all-cause mortality, (re)hospitalisation for worsening heart failure, non-fatal myocardial infarction, non-fatal stroke of any aetiology and major haemorrhage.Results: Five trials were identified that met the prespecified search criteria. Compared with control therapy, anticoagulant treatment did not reduce all-cause mortality (risk ratio [RR] 0.99, 95% CI 0.90 to 1.08), (re)hospitalisation for heart failure (RR 0.97, 95% CI 0.82 to 1.13) or non-fatal myocardial infarction (RR 0.92, 95% CI 0.75 to 1.13). Anticoagulation did reduce the rate of non-fatal stroke (RR 0.63, 95% CI 0.49 to 0.81, p=0.001), but this was offset by an increase in the incidence of major haemorrhage (RR 1.88, 95% CI 1.49 to 2.38, p=0.001).Conclusions: Our meta-analysis provides evidence to oppose the hypothesis that thrombosis or embolism plays an important role in the morbidity and mortality associated with HFrEF, with the exception of stroke-related morbidity. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
42. Risk of cardiac and sudden death with and without revascularisation of a coronary chronic total occlusion.
- Author
-
Godino, Cosmo, Giannattasio, Alessia, Scotti, Andrea, Baldetti, Luca, Pivato, Carlo Andrea, Munafò, Andrea, Cappelletti, Alberto, Beneduce, Alessandro, Melillo, Francesco, Chiarito, Mauro, Zoccai, Giuseppe Biondi, Frati, Giacomo, Fragasso, Gabriele, Azzalini, Lorenzo, Carlino, Mauro, Montorfano, Matteo, Margonato, Alberto, Colombo, Antonio, and Biondi Zoccai, Giuseppe
- Subjects
CARDIAC arrest ,GENERAL practitioners - Abstract
Objective: The aim of this study is to evaluate the long-term risk of cardiac death and sudden cardiac death (SCD) and/or sustained ventricular arrhythmias (SVAs) in patients with coronary chronic total occlusions (CTO) revascularised versus those with CTO not revascularised by percutaneous coronary intervention (PCI).Methods: From a cohort of 1357 CTO-PCI patients, 1162 patients who underwent CTO PCI attempt were included in this long-term analysis: 837 patients were revascularised by PCI (CTO-R group) and 325 were not revascularised (CTO-NR group). Primary adverse endpoint was the incidence of cardiac death; secondary endpoint was the cumulative incidence of SCD/SVAs.Results: Up to 12-year follow-up (median 6 year), compared with CTO-R patients, those with CTO-NR had significantly higher rate of cardiac death (13%[43/325]vs6%[48/837]; p<0.001) and SCD/SVAs (7.5%[24/325]vs2.5%[20/837]; p<0.001). The risk of cardiac death and SCD/SVAs was mainly driven by the subgroup of infarct-related artery (IRA) CTO patients and was significantly higher only in IRA CTO-NR patients (18%vs7%, p<0.001, 14%vs5%, p=0.001; IRA CTO-NR vs IRA CTO-R, respectively). At multivariable Cox hazards regression analysis, CTO-NR remains one of the strongest independent predictors of higher risk of cardiac death and of SCD/SVAs in the overall population and in IRA CTO patients.Conclusions: At long-term follow-up, patients with CTO not revascularised by PCI had worse outcomes compared with those with CTO revascularised, with >2-fold risk of cardiac death and threefold risk of SCD/SVAs. The presence of an infarct-related artery (IRA CTO) not revascularised identified the category of patients with the highest rate of adverse events . [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
43. Arrhythmogenic cardiomyopathies (ACs): diagnosis, risk stratification and management.
- Author
-
Protonotarios, Alexandros and Elliott, Perry M.
- Subjects
ARRHYTHMOGENIC right ventricular dysplasia ,CARDIOMYOPATHIES ,RISK management in business ,MYOCARDIUM ,CARDIAC magnetic resonance imaging ,ARRHYTHMIA diagnosis ,ARRHYTHMIA ,CARDIAC arrest ,DIFFERENTIAL diagnosis ,FAMILY health ,RISK assessment ,DISEASE management ,DILATED cardiomyopathy ,DISEASE complications - Published
- 2019
- Full Text
- View/download PDF
44. Left ventricular mechanical dispersion predicts arrhythmic risk in mitral valve prolapse.
- Author
-
Ermakov, Simon, Gulhar, Radhika, Lim, Lisa, Bibby, Dwight, Qizhi Fang, Nah, Gregory, Abraham, Theodore P., Schiller, Nelson B., Delling, Francesca N., and Fang, Qizhi
- Subjects
MITRAL valve prolapse ,DISPERSION (Chemistry) ,HEART valve diseases - Abstract
Objective: Bileaflet mitral valve prolapse (MVP) with either focal or diffuse myocardial fibrosis has been linked to ventricular arrhythmia and/or sudden cardiac arrest. Left ventricular (LV) mechanical dispersion by speckle-tracking echocardiography (STE) is a measure of heterogeneity of ventricular contraction previously associated with myocardial fibrosis. The aim of this study is to determine whether mechanical dispersion can identify MVP at higher arrhythmic risk.Methods: We identified 32 consecutive arrhythmic MVPs (A-MVP) with a history of complex ventricular ectopy on Holter/event monitor (n=23) or defibrillator placement (n=9) along with 27 MVPs without arrhythmic complications (NA-MVP) and 39 controls. STE was performed to calculate global longitudinal strain (GLS) as the average peak longitudinal strain from an 18-segment LV model and mechanical dispersion as the SD of the time to peak strain of each segment.Results: MVPs had significantly higher mechanical dispersion compared with controls (52 vs 42 ms, p=0.005) despite similar LV ejection fraction (62% vs 63%, p=0.42) and GLS (-19.7 vs -21, p=0.045). A-MVP and NA-MVP had similar demographics, LV ejection fraction and GLS (all p>0.05). A-MVP had more bileaflet prolapse (69% vs 44%, p=0.031) with a similar degree of mitral regurgitation (mostly trace or mild in both groups) (p>0.05). A-MVP exhibited greater mechanical dispersion when compared with NA-MVP (59 vs 43 ms, p=0.0002). Mechanical dispersion was the only significant predictor of arrhythmic risk on multivariate analysis (OR 1.1, 95% CI 1.02 to 1.11, p=0.006).Conclusions: STE-derived mechanical dispersion may help identify MVP patients at higher arrhythmic risk. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
45. Effectiveness of the 2014 European Society of Cardiology guideline on sudden cardiac death in hypertrophic cardiomyopathy: a systematic review and meta-analysis.
- Author
-
O'Mahony, Constantinos, Akhtar, Mohammed Majid, Anastasiou, Zacharias, Guttmann, Oliver P., Vriesendorp, Pieter A., Michels, Michelle, Magrì, Damiano, Autore, Camillo, Fernández, Adrián, Ochoa, Juan Pablo, Leong, Kevin M. W., Varnava, Amanda M., Monserrat, Lorenzo, Anastasakis, Aristides, Garcia-Pavia, Pablo, Rapezzi, Claudio, Biagini, Elena, Gimeno, Juan Ramon, Limongelli, Giuseppe, and Omar, Rumana Z.
- Subjects
CARDIAC arrest ,HYPERTROPHIC cardiomyopathy ,META-analysis ,CARDIOLOGY ,IMPLANTABLE cardioverter-defibrillators ,CARDIAC arrest prevention ,COMPARATIVE studies ,CARDIAC hypertrophy ,RESEARCH methodology ,MEDICAL cooperation ,MEDICAL protocols ,PREVENTIVE health services ,RESEARCH ,RESEARCH funding ,RISK assessment ,SYSTEMATIC reviews ,EVALUATION research ,DISEASE complications - Abstract
Objective: In 2014, the European Society of Cardiology (ESC) recommended the use of a novel risk prediction model (HCM Risk-SCD) to guide use of implantable cardioverter defibrillators (ICD) for the primary prevention of sudden cardiac death (SCD) in patients with hypertrophic cardiomyopathy (HCM). We sought to determine the performance of HCM Risk-SCD by conducting a systematic review and meta-analysis of articles reporting on the prevalence of SCD within 5 years of evaluation in low, intermediate and high-risk patients as defined by the 2014 guidelines (predicted risk <4%, 4%-<6% and ≥6%, respectively).Methods: The protocol was registered with PROSPERO (registration number: CRD42017064203). MEDLINE and manual searches for papers published from October 2014 to December 2017 were performed. Longitudinal, observational cohorts of unselected adult patients, without history of cardiac arrest were considered. The original HCM Risk-SCD development study was included a priori. Data were pooled using a random effects model.Results: Six (0.9%) out of 653 independent publications identified by the initial search were included. The calculated 5-year risk of SCD was reported in 7291 individuals (70% low, 15% intermediate; 15% high risk) with 184 (2.5%) SCD endpoints within 5 years of baseline evaluation. Most SCD endpoints (68%) occurred in patients with an estimated 5-year risk of ≥4% who formed 30% of the total study cohort. Using the random effects method, the pooled prevalence of SCD endpoints was 1.01% (95% CI 0.52 to 1.61) in low-risk patients, 2.43% (95% CI 1.23 to 3.92) in intermediate and 8.4% (95% CI 6.68 to 10.25) in high-risk patients.Conclusions: This meta-analysis demonstrates that HCM Risk-SCD provides accurate risk estimations that can be used to guide ICD therapy in accordance with the 2014 ESC guidelines.Registration Number: PROSPERO CRD42017064203;Pre-results. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
46. Survival after out-of-hospital cardiac arrest is associated with area-level socioeconomic status.
- Author
-
Jonsson, Martin, Härkönen, Juho, Ljungman, Petter, Rawshani, Araz, Nordberg, Per, Svensson, Leif, Herlitz, Johan, and Hollenberg, Jacob
- Subjects
CARDIAC arrest ,SOCIAL status ,EMERGENCY medical services ,DISPOSABLE income ,MEDICAL care standards ,CARDIOPULMONARY resuscitation ,INCOME ,MEDICAL care ,PATIENTS ,PROBABILITY theory ,SEX distribution ,SOCIAL classes ,SURVIVAL analysis (Biometry) ,RESIDENTIAL patterns ,EDUCATIONAL attainment - Abstract
Objective: Out-of-hospital cardiac arrest (OHCA) is a major cause of death in the Western world. In this study we aimed to investigate the relationship between area-level socioeconomic status (SES) and 30-day survival after OHCA. We hypothesised that high SES at an area level is associated with an improved chance of 30-day survival.Methods: Patients with OHCA in Stockholm County between 1 January 2006 and 31 December 2015 were analysed retrospectively. To quantify area-level SES, we linked the patient's home address to 250 × 250/1000 × 1000 meter grids with aggregated information about income and education. We constructed multivariable logistic regression models in which area-level SES measures were adjusted for age, sex, emergency medical services response time, witnessed status, initial rhythm, aetiology, location and year of cardiac arrest.Results: We included 7431 OHCAs. There was significantly greater 30-day survival (p=0.003) in areas with a high proportion of university-educated people. No statistically significant association was seen between median disposable income and 30-day survival. The adjusted OR for 30-day survival among patients in the highest educational quintile was 1.70 (95% CI 1.15 to 2.51) compared with patients in the lowest educational quintile. We found no significant interaction for sex. Positive trend with increasing area-level education was seen in both men and women but the trend was only statistically significant among men (p=0.012) CONCLUSIONS: Survival to 30 days after OHCA is positively associated with the average educational level of the residential area. Area-level income does not independently predict 30-day survival after OHCA. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
47. Predictors of electrocardiographic QT interval prolongation in men with HIV.
- Author
-
Wu, Katherine C., Long Zhang, Haberlen, Sabina A., Ashikaga, Hiroshi, Brown, Todd T., Budoff, Matthew J., D'Souza, Gypsyamber, Kingsley, Lawrence A., Palella, Frank J., Margolick, Joseph B., Martínez-Maza, Otoniel, Soliman, Elsayed Z., Post, Wendy S., and Zhang, Long
- Subjects
TALL-1 (Protein) ,CARDIAC arrest ,VENTRICULAR arrhythmia ,HIV infections ,CELL adhesion ,CARDIAC arrest prevention ,LONG QT syndrome diagnosis ,HIV infection complications ,HIV infection epidemiology ,ANTIGENS ,ELECTROCARDIOGRAPHY ,INTERLEUKINS ,RESEARCH funding ,RISK assessment ,SERODIAGNOSIS ,TUMOR necrosis factors ,ANTIRETROVIRAL agents ,LONG QT syndrome - Abstract
Objective: HIV-infected (HIV+) individuals may be at increased risk for sudden arrhythmic cardiac death. Some studies have reported an association between HIV infection and prolongation of the electrocardiographic QT interval, a measure of ventricular repolarisation, which could potentiate ventricular arrhythmias. We aimed to assess whether HIV+ men have longer QT intervals than HIV-uninfected (HIV-) men and to determine factors associated with QT duration.Methods: We performed resting 12-lead ECGs in 774 HIV+ and 652 HIV- men in the Multicenter AIDS Cohort Study (MACS). We used multivariable linear and logistic regression analyses to assess associations between HIV serostatus and Framingham corrected QT interval (QTc), after accounting for potential confounders. We also determined associations among QTc interval and HIV-related factors in HIV+ men. In a subgroup of participants, levels of serum markers of inflammation were also assessed.Results: After adjusting for demographics and risk factors, QTc was 4.0 ms longer in HIV+ than HIV- men (p<0.001). Use of antiretroviral therapy (ART), specific ART drug class use and other HIV-specific risk factors were not associated with longer QTc. Among the subgroup with inflammatory biomarker measurements, higher interleukin-6 (IL-6), intercellular adhesion molecule-1 (ICAM-1) and B-cell activating factor levels were independently associated with longer QTc and their inclusion partially attenuated the HIV effect.Conclusions: HIV+ men had longer QTc, which was associated with higher levels of systemic inflammatory factors. This longer QTc may contribute to the increased risk for sudden arrhythmic cardiac death in some HIV+ individuals. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
48. Towards cardiac MRI based risk stratification in idiopathic dilated cardiomyopathy.
- Author
-
Brown, Pamela Frances, Miller, Chris, Di Marco, Andrea, and Schmitt, Matthias
- Subjects
IMPLANTABLE cardioverter-defibrillators ,CARDIOMYOPATHIES ,DILATED cardiomyopathy ,CARDIAC magnetic resonance imaging ,RISK assessment ,CARDIAC arrest - Published
- 2019
- Full Text
- View/download PDF
49. Diagnostic accuracy and Bayesian analysis of new international ECG recommendations in paediatric athletes.
- Author
-
McClean, Gavin, Riding, Nathan R., Pieles, Guido, Watt, Victoria, Adamuz, Carmen, Sharma, Sanjay, George, Keith P., Oxborough, David, and Wilson, Mathew G.
- Subjects
MALE athletes ,ATHLETES ,BAYESIAN analysis ,ARABS ,ELECTROCARDIOGRAPHY ,BLACK people ,HEART disease diagnosis ,CHILD athletes ,CARDIAC arrest ,HEART disease complications ,ECHOCARDIOGRAPHY ,HEART diseases ,MEDICAL protocols ,MEDICAL screening ,PROBABILITY theory ,RESEARCH evaluation ,DISEASE incidence ,RETROSPECTIVE studies ,RECEIVER operating characteristic curves - Abstract
Objective: Historically, electrocardiographic (ECG) interpretation criteria for athletes were only applicable to adults. New international recommendations now account for athletes ≤16 years, but their clinical appropriateness is unknown. We sought to establish the diagnostic accuracy of new international ECG recommendations against the Seattle criteria and 2010 European Society of Cardiology (ESC) recommendations in paediatric athletes using receiver operator curve analysis. Clinical context was calculated using Bayesian analysis.Methods: 876 Arab and 428 black male paediatric athletes (11-18 years) were evaluated by medical questionnaire, physical examination, ECG and echocardiographic assessment. ECGs were retrospectively analysed according to the three criteria.Results: Thirteen (1.0%) athletes were diagnosed with cardiac pathology that may predispose to sudden cardiac arrest/death (SCA/D) (8 (0.9%) Arab and (5 (1.2%) black)). Diagnostic accuracy was poor (0.68, 95% CI 0.54 to 0.82) for 2010 ESC recommendations, fair (0.70, 95% CI 0.54 to 0.85) for Seattle criteria and fair (0.77, 95% CI 0.61 to 0.93) for international recommendations. False-positive rates were 41.0% for 2010 ESC recommendations, 21.8% for Seattle criteria and 6.8% for international recommendations. International recommendations provided a positive (+LR) and negative (-LR) post-test likelihood ratio of 9.0 (95% CI 5.1 to 13.1) and 0.4 (95% CI 0.2 to 0.7), respectively.Conclusion: In Arab and black male paediatric athletes, new international recommendations outperform both the Seattle criteria and 2010 ESC recommendations, reducing false positive rates, while yielding a 'fair' diagnostic accuracy for cardiac pathology that may predispose to SCA/D. In clinical context, the 'chance' of detecting cardiac pathology within a paediatric male athlete with a positive ECG (+LR=9.0) was 8.3%, whereas a negative ECG (-LR=0.4) was 0.4%. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
50. Mitral valve prolapse and sudden cardiac death: a systematic review and meta-analysis.
- Author
-
Nalliah, Chrishan J., Mahajan, Rajiv, Elliott, Adrian D., Haqqani, Haris, Lau, Dennis H., Vohra, Jitendra K., Morton, Joseph B., Semsarian, Christopher, Marwick, Thomas, Kalman, Jonathan M., and Sanders, Prashanthan
- Subjects
MITRAL valve prolapse ,CARDIAC arrest ,MEDICAL literature ,META-analysis ,AT-risk people ,FIBROSIS ,COMPARATIVE studies ,ECHOCARDIOGRAPHY ,HEART ventricles ,RESEARCH methodology ,MEDICAL cooperation ,RESEARCH ,WORLD health ,SYSTEMATIC reviews ,EVALUATION research ,DISEASE incidence ,DISEASE complications - Abstract
Objectives: Mitral valve prolapse (MVP) is commonly observed as a benign finding. However, the literature suggests that it may be associated with sudden cardiac death (SCD). We performed a meta-analysis and systematic review to determine the: (1) prevalence of MVP in the general population; (2) prevalence of MVP in all SCD and unexplained SCD; (3) incidence of SCD in MVP and (4) risk factors for SCD.Methods: The English medical literature was searched for: (1) MVP community prevalence; (2) MVP prevalence in SCD cohorts; (3) incidence SCD in MVP and (4) SCD risk factors in MVP. Thirty-four studies were identified for inclusion. This study was registered with PROSPERO (CRD42018089502).Results: The prevalence of MVP was 1.2% (95% CI 0.5 to 2.0) in community populations. Among SCD victims, the cause of death remained undetermined in 22.1% (95% CI 13.4 to 30.7); of these, MVP was observed in 11.7% (95% CI 5.8 to 19.1). The incidence of SCD in the MVP population was 0.14% (95% CI 0.1 to 0.3) per year. Potential risk factors for SCD include bileaflet prolapse, ventricular fibrosis complex ventricular ectopy and ST-T wave abnormalities.Conclusion: The high prevalence of MVP in cohorts of unexplained SCD despite low population prevalence provides indirect evidence of an association of MVP with SCD. The absolute number of people exposed to the risk of SCD is significant, although the incidence of life-threatening arrhythmic events in the general MVP population remains low. High-risk features include bileaflet prolapse, ventricular fibrosis, ST-T wave abnormalities and frequent complex ventricular ectopy.Trial Registration: PROSPERO (CRD42018089502). [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.